May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Risk Factors for Elevated Intraocular Pressure After Trans–Tenon’s or Intravitreal Injections of Triamcinolone
Author Affiliations & Notes
  • H. Takenaka
    Ophthalmology, Kagawa Medical University School of Medicine, Miki, Japan
  • K. Hirooka
    Ophthalmology, Kagawa Medical University School of Medicine, Miki, Japan
  • T. Baba
    Ophthalmology, Kagawa Medical University School of Medicine, Miki, Japan
  • H. Yamazi
    Ophthalmology, Kagawa Medical University School of Medicine, Miki, Japan
  • H. Nomoto
    Ophthalmology, Kagawa Medical University School of Medicine, Miki, Japan
  • F. Shiraga
    Ophthalmology, Kagawa Medical University School of Medicine, Miki, Japan
  • Footnotes
    Commercial Relationships  H. Takenaka, None; K. Hirooka, None; T. Baba, None; H. Yamazi, None; H. Nomoto, None; F. Shiraga, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 136. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Takenaka, K. Hirooka, T. Baba, H. Yamazi, H. Nomoto, F. Shiraga; Risk Factors for Elevated Intraocular Pressure After Trans–Tenon’s or Intravitreal Injections of Triamcinolone . Invest. Ophthalmol. Vis. Sci. 2005;46(13):136.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To investigate risk factors for elevated intraocular pressure after either trans–Tenon’s retrobulbar or intravitreal injections of triamcinolone acetonide. Methods: Retrospective review of 94 eyes of 94 consecutive patients with choroidal neovascularization or diffuse diabetic macular edema that received either trans–Tenon’s retrobulbar injection of triamcinolone acetonide (20 mg) or intravitral injection of triamcinolone acetonide (4 or 8 mg). Steroid responders were defined as having a relative intraocular pressure increase of 6 mmHg and an absolute intraocular pressure greater than 20 mmHg with an anatomically open angle. Results: 28 eyes were responders and 66 eyes were nonresponders. Elevation of intraocular pressure occurred one to eight weeks after the injection. The preoperative predictive factors for the steroid responders were both diabetes mellitus (multiple logistic regression, p = 0.01) and patient age (p = 0.04). Three eyes of the 28 steroid responders needed trabeculotomy to control intraocular pressure. Conclusions: Our results suggest that risk factors for elevated intraocular pressure after triamcinolone injections could be diabetes mellitus and patient age.

Keywords: corticosteroids • clinical (human) or epidemiologic studies: risk factor assessment • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×